Laboratory Competitors
| LH Stock | USD 282.63 4.52 1.63% |
Laboratory vs United Therapeutics Correlation
Excellent diversification
The correlation between Laboratory of and UTHR is -0.56 (i.e., Excellent diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Laboratory of and UTHR in the same portfolio, assuming nothing else is changed.
Moving against Laboratory Stock
| 0.65 | UNH | UnitedHealth Group CDR | PairCorr |
| 0.64 | V3V | VITA 34 AG | PairCorr |
| 0.59 | CV | CapsoVision Common Stock | PairCorr |
Laboratory Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Laboratory and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Laboratory and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Laboratory does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Laboratory Stock performing well and Laboratory Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Laboratory's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| WAT | 1.23 | (0.28) | 0.00 | (0.19) | 0.00 | 3.25 | 18.00 | |||
| DGX | 1.13 | 0.18 | 0.11 | 1.17 | 0.96 | 2.75 | 8.55 | |||
| ZBH | 1.15 | 0.09 | 0.06 | 0.17 | 1.17 | 2.92 | 7.20 | |||
| WST | 1.59 | (0.23) | 0.00 | (0.08) | 0.00 | 2.82 | 12.18 | |||
| ILMN | 1.85 | (0.05) | 0.00 | (0.20) | 0.00 | 3.85 | 15.59 | |||
| DXCM | 1.47 | 0.33 | 0.18 | 0.46 | 1.29 | 3.31 | 10.50 | |||
| STE | 1.03 | (0.15) | 0.00 | (0.08) | 0.00 | 1.79 | 10.43 | |||
| BIIB | 1.54 | 0.31 | 0.15 | 0.40 | 1.72 | 4.38 | 12.20 | |||
| INCY | 1.63 | (0.12) | 0.00 | (0.05) | 0.00 | 4.10 | 13.76 | |||
| UTHR | 0.96 | 0.04 | 0.00 | 0.19 | 1.16 | 1.94 | 5.21 |
Cross Equities Net Income Analysis
Compare Laboratory and related stocks such as Waters, Quest Diagnostics, and Zimmer Biomet Holdings Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| WAT | 2 M | 433 M | 461.4 M | 450 M | 431.6 M | 469.1 M | 521.5 M | 20.3 M | 593.8 M | 592.2 M | 521.6 M | 692.8 M | 707.8 M | 642.2 M | 637.8 M | 642.6 M | 373.6 M |
| DGX | (626 M) | 470.6 M | 555.7 M | 849 M | 556 M | 709 M | 645 M | 772 M | 736 M | 858 M | 1.4 B | 2 B | 946 M | 854 M | 871 M | 992 M | 646.9 M |
| ZBH | 145 M | 760.8 M | 755 M | 761 M | 720.3 M | 147 M | 305.9 M | 1.8 B | (379.2 M) | 1.1 B | (138.9 M) | 401.6 M | 231.4 M | 1 B | 903.8 M | 705.2 M | 605.5 M |
| WST | 15 M | 75.5 M | 80.7 M | 112.3 M | 127.1 M | 95.6 M | 143.6 M | 150.7 M | 206.9 M | 241.7 M | 346.2 M | 661.8 M | 585.9 M | 593.4 M | 492.7 M | 493.7 M | 518.4 M |
| ILMN | (5.5 M) | 86.6 M | 151.3 M | 125.3 M | 353.4 M | 461.6 M | 462.6 M | 726 M | 826 M | 1 B | 656 M | 762 M | (4.4 B) | (1.2 B) | (1.2 B) | 850 M | 892.5 M |
| DXCM | (4 M) | (44.7 M) | (54.5 M) | (29.8 M) | (22.4 M) | (57.6 M) | (65.6 M) | (50.2 M) | (127.1 M) | 101.1 M | 493.6 M | 216.9 M | 341.2 M | 541.5 M | 576.2 M | 836.3 M | 878.1 M |
| STE | 2.5 M | 136.1 M | 160 M | 129.4 M | 135.1 M | 110.8 M | 110 M | 290.9 M | 304.1 M | 407.7 M | 397.4 M | 243.9 M | 107 M | 378.2 M | 614.6 M | 706.8 M | 742.2 M |
| BIIB | (19.1 M) | 1.2 B | 1.4 B | 1.9 B | 2.9 B | 3.5 B | 3.7 B | 2.5 B | 4.4 B | 5.9 B | 4 B | 1.6 B | 3 B | 1.2 B | 1.6 B | 1.3 B | 1.2 B |
| INCY | (4.9 M) | (186.5 M) | (44.3 M) | (83.1 M) | (48.5 M) | 6.5 M | 104.2 M | (313.1 M) | 109.5 M | 446.9 M | (295.7 M) | 948.6 M | 340.7 M | 597.6 M | 32.6 M | 1.3 B | 1.4 B |
| UTHR | (12.8 M) | 217.9 M | 304.4 M | 174.6 M | 340.1 M | 651.6 M | 713.7 M | 417.9 M | 589.2 M | (104.5 M) | 514.8 M | 475.8 M | 727.3 M | 984.8 M | 1.2 B | 1.4 B | 1.4 B |
Laboratory and related stocks such as Waters, Quest Diagnostics, and Zimmer Biomet Holdings Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Laboratory financial statement analysis. It represents the amount of money remaining after all of Laboratory of operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Laboratory Competitive Analysis
The better you understand Laboratory competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Laboratory's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Laboratory's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Laboratory Competition Performance Charts
Five steps to successful analysis of Laboratory Competition
Laboratory's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Laboratory in relation to its competition. Laboratory's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Laboratory in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Laboratory's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Laboratory, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Laboratory position
In addition to having Laboratory in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Soft Drinks Thematic Idea Now
Soft Drinks
Entities manufacturing and distributing non alcoholic beverages across different markets. The Soft Drinks theme has 12 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Soft Drinks Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Laboratory Correlation with its peers. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is there potential for Health Care Providers & Services market expansion? Will Laboratory introduce new products? Factors like these will boost the valuation of Laboratory. Expected growth trajectory for Laboratory significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.56 | Dividend Share 2.88 | Earnings Share 10.18 | Revenue Per Share | Quarterly Revenue Growth 0.086 |
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Laboratory's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Laboratory represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Laboratory's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.